newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024

Live webcast discussion featuring internationally renowned Glioblastoma Multiforme Key Opinion LeadersCompany committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to